Meeting Banner
Abstract #2691

MRI of the Lung to monitoring cystic fibrosis (CF) patients with pulmonary exacerbation

Giovanni Morana 1 , Federica De Leo 1 , Valentina Tavano 2 , Andrea Mazzaro 2 , Mirco Ros 3 , Francesca Lucca 3 , Pierluigi Ciet 4 , and Silvia Bertolo 1

1 Radiology, Ca' Foncello Hospital, Treviso, Treviso, Italy, 2 Padova's Hospital, Padova, Padova, Italy, 3 Pediatrics, Ca' Foncello Hospital, Treviso, Treviso, Italy, 4 Radiology and Pediatrics Pulmonology, Erasmus MC, Rotterdam, Rotterdam, Netherlands

Cystic Fibrosis is the most common lethal hereditary disease in the caucasian population. Currently, no sensitive, radiation-free methods are available to localize and quantify lung inflammation. Developments in MRI have made possible the clinical application of lung-MRI to obtain not only morphological but also functional information. Our propose is giving an overview of these new MR tecniques and their potential application in CF population. Lung-MRI has the potential to supply new relevant functional information in thoracic imaging. Its impact in CF follow-up has still to be defined, but it might open new therapeutic scenarios in CF and in other lung disease.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords